Table 1. Clinicopathological features of aSAH according to 1-year outcome.
| Clinicopathological parameters | mRS 0–2, n=111 | mRS 3–5, n=17 | P-value |
|---|---|---|---|
| Sex; Male | 47 | 7 | 0.93 |
| Sex; Female | 64 | 10 | |
| Age; <59 | 51 | 4 | 0.08 |
| Age; ≥59 | 60 | 13 | |
| Hypertension; Yes | 42 | 7 | 0.79 |
| Hypertension; No | 69 | 10 | |
| Smoking; Yes | 40 | 8 | 0.38 |
| Smoking; No | 71 | 9 | |
| WFNS Grade; I | 50 | 0 | <0.001 |
| WFNS Grade; II | 32 | 0 | |
| WFNS Grade; III | 24 | 5 | |
| WFNS Grade; IV | 5 | 10 | |
| WFNS Grade; V | 0 | 2 | |
| Hunt–Hess Grade; I | 44 | 0 | <0.001 |
| Hunt–Hess Grade; II | 53 | 1 | |
| Hunt–Hess Grade; III | 13 | 10 | |
| Hunt–Hess Grade; IV | 1 | 6 | |
| Hunt–Hess Grade; V | 0 | 0 | |
| Fisher Score; I | 33 | 0 | <0.001 |
| Fisher Score; II | 46 | 1 | |
| Fisher Score; III | 25 | 4 | |
| Fisher Score; IV | 7 | 12 |
The median age was 59 years.